at the CNIO

Author: Sabio lab (Page 13 of 62)

Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis

Ivana Nikoli?, Irene Ruiz-Garrido, María Crespo, Rafael Romero-Becerra, Luis Leiva-Vega, Alfonso Mora, Marta León, Elena Rodríguez, Magdalena Leiva, Ana Belén Plata-Gómez, Maria Beatriz Alvarez Flores, Jorge L Torres, Lourdes Hernández-Cosido, Juan Antonio López, Jesús Vázquez, Alejo Efeyan, Pilar Martin, Miguel Marcos & Guadalupe Sabio.

Obesity is characterized by low-grade inflammation, energy imbalance and impaired thermogenesis. The role of regulatory T cells (Treg) in inflammation-mediated maladaptive thermogenesis is not well established.

Reduction of fat mass of mice lacking MKK3/6 as seen by MRI (Image: Ivana Nikoli?).

Here, we find that the p38 pathway is a key regulator of T cell-mediated adipose tissue (AT) inflammation and browning. Mice with T cells specifically lacking the p38 activators MKK3/6 are protected against diet-induced obesity, leading to an improved metabolic profile, increased browning, and enhanced thermogenesis. We identify IL-35 as a driver of adipocyte thermogenic program through the ATF2/UCP1/FGF21 pathway. IL-35 limits CD8+ T cell infiltration and inflammation in AT. Interestingly, we find that IL-35 levels are reduced in visceral fat from obese patients.

Mechanistically, we demonstrate that p38 controls the expression of IL-35 in human and mouse Treg cells through mTOR pathway activation. Our findings highlight p38 signaling as a molecular orchestrator of AT T cell accumulation and function.

«Estoy centrada en ver cómo afecta la obesidad a los distintos tipos de cáncer»

«Hay una población de gente con obesidad: unos que van a tener diabetes, otros un tipo de cáncer, otros enfermedad cardíaca y otros problemas de riñón. Si somos capaces de estratificar y entender cuáles van a desarrollar cada enfermedad, podremos desarrollar un protocolo de diagnóstico precoz, un control posterior para anticiparnos en los tratamientos y poder curarlos».

Guadalupe Sabio: «el número de personas que muere a causa de la obesidad es equiparable al número de personas que muere a causa del tabaco».

Senior researcher (César Nombela grant)

Within the 2024 call of the Talented Research Scientists Recruitment Programme, “César Nombela” grants, we are looking for a scientist who have obtained a PhD between January 1st, 2014 and December 31st, 2021.

The Programme grants a full-time Senior researcher position for 5 years to experienced PhDs who have carried out pre-doctoral and/or post-doctoral stays in an R&D centre outside Spain. Additional funds (up to 200,000 €) will also be granted for the development of the research project.

In order to complete all the necessary internal procedures, please contact Dr Guadalupe Sabio. Applications must be submitted before 6 May 2024.

Beneficiares:

  • Open to candidates of any nationality (regardless of where the PhD degree was obtained).
  • PhD degree obtained between January 1st, 2014 and December 31st, 2021.
  • Candidates must have been employed in a foreign research centre (as a predoctoral or postdoctoral researcher) for a minimum period of 2 years out of the last five years.

Gross salary: 40,000 € (years 1-3), 47,000 € (years 4-5, in the case that the doctoral researcher has obtained the R3 certificate accrediting the positive evaluation as an established researcher).

« Older posts Newer posts »

© 2026 Sabio lab

Theme by Anders Norén — Up ↑